{"organizations": [], "uuid": "9ebc092f8ae1a597f8d4f3cbf59e143848e0ed82", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 6}, "vk": {"shares": 1}, "linkedin": {"shares": 57}, "facebook": {"likes": 6486, "shares": 6486, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://si.wsj.net/public/resources/images/BN-XF596_3mnZy_TOP_20180130061001.jpg", "site_section": "https://www.wsj.com/public/page/archive.html", "section_title": "News Article Archive - Wsj.com", "url": "https://www.wsj.com/articles/pfizer-plans-5-billion-boost-in-u-s-manufacturing-from-tax-law-changes-1517319342", "country": "US", "domain_rank": 387, "title": "Pfizer Plans $5 Billion Boost in U.S. Manufacturing From Tax Law Changes", "performance_score": 10, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-30T22:00:00.000+02:00", "replies_count": 0, "uuid": "9ebc092f8ae1a597f8d4f3cbf59e143848e0ed82"}, "author": "Jonathan D. Rockoff", "url": "https://www.wsj.com/articles/pfizer-plans-5-billion-boost-in-u-s-manufacturing-from-tax-law-changes-1517319342", "ord_in_thread": 0, "title": "Pfizer Plans $5 Billion Boost in U.S. Manufacturing From Tax Law Changes", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "pfizer", "sentiment": "negative"}, {"name": "u.s. manufacturing from tax law changes pfizer inc.", "sentiment": "negative"}, {"name": "amazon.com inc.-led", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Pfizer Inc. offered a rosy outlook for the year, outlining the benefits from the new U.S. tax law and casting the Amazon.com Inc.-led partnership to lower health-care costs as positive for the drug industry.\nNew York-based Pfizer reported for the fourth quarter a profit of $12.27 billion, or $2.02 a share, up from $775 million, or 13 cents a share, a year earlier. The big gain came largely from a $10.7 billion benefit from the revaluation of deferred tax liabilities.\n... ", "external_links": [], "published": "2018-01-30T22:00:00.000+02:00", "crawled": "2018-01-31T01:48:20.000+02:00", "highlightTitle": ""}